Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novasep, a French manufacturing solutions provider, has received the US Food and Drug Administration (FDA) green signal for two of its Synthesis sites, Freeport (the Bahamas) facility in March and Chasse sur Rhone (Lyon, France) facility in May, this year.
Subscribe to our email newsletter
Chasse-sur-Rhone provides for process scale-ups, the supply of clinical batches and the regular production of low volume compounds under cGMP.
Freeport site performs custom manufacturing services from late stage clinical trials through to multi-ton commercial production for API’s
Novasep Synthesis president Patrick Glaser said their scope of synthesis and purification technologies and know-how enables them to produce the increasingly complex molecules with purity.
Novasep Synthesis is the synthetic molecule contract manufacturing division of Novasep.